South Western Sydney Clinical School

Wilson BE; Jacob S; Yap ML; Ferlay J; Bray F; Barton MB, 2019, 'Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study', The Lancet Oncology, vol. 20, pp. 769 - 780, http://dx.doi.org/10.1016/S1470-2045(19)30163-9

Do V; Ng W; Jacob S; Delaney GP; Barton M, 2017, 'An estimation of the population survival benefit of first-course chemotherapy for head and neck cancers', Annals of Oncology, vol. 28, pp. v388 - v388, http://dx.doi.org/10.1093/annonc/mdx374.043

Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB, 2016, 'Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines', Radiotherapy and Oncology, vol. 118, pp. 118 - 121, http://dx.doi.org/10.1016/j.radonc.2015.12.023

Do V; Jacob S; Ng W; Delaney GP; Barton MB, 2016, '346P An estimation of the population survival benefit of first-course chemotherapy and immunotherapy for leukemia', Annals of Oncology, vol. 27, pp. ix108 - ix108, http://dx.doi.org/10.1016/s0923-7534(21)00504-4

Jacob SA; Ng WL; Do V, 2015, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Cancer: Setting an Evidence-based Benchmark for Quality Cancer Care', Clinical Oncology, vol. 27, pp. 77 - 82, http://dx.doi.org/10.1016/j.clon.2014.10.004

Ng W; Jacob S; Delaney G; Do V; Barton M, 2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, vol. 2015, http://dx.doi.org/10.1155/2015/753480

Do V; Ng W; Jacob S; Delaney G; Barton M, 2015, 'An Estimation of the Population-Based Survival Benefit of First-Line Chemotherapy for Lung Cancer', Annals of Oncology, vol. 26, pp. i29 - i29, http://dx.doi.org/10.1093/annonc/mdv050.37

Do V; Jacob S; Ng W; Delaney GP; Barton MB, 2015, '120PD An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour', Annals of Oncology, vol. 26, pp. ix34 - ix34, http://dx.doi.org/10.1093/annonc/mdv520.04

Barton MB; Jacob S; Shafiq J; Wong K; Thompson SR; Hanna TP; Delaney GP, 2014, 'Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012', Radiotherapy and Oncology, vol. 112, pp. 140 - 144, http://dx.doi.org/10.1016/j.radonc.2014.03.024

Barton MB; Shafiq RJ; Jacob S; Wong K; Delaney GP; Hanna TP, 2013, 'OC-0367: New evidence-based benchmarks for radiotherapy service provision', Radiotherapy and Oncology, vol. 106, pp. S143 - S144, http://dx.doi.org/10.1016/s0167-8140(15)32673-6

Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB, 2012, 'Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care', Journal of medical imaging & radiation oncology, vol. 56, pp. 483 - 489, http://dx.doi.org/10.1111/j.1754-9485.2012.02392.x

Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy', Breast, vol. 21, pp. 562 - 569, http://dx.doi.org/10.1016/j.breast.2012.01.006

Simunovic M; Jacob S; Coates AJ; Vogt K; Moran BJ; Heald RJ, 2011, 'Outcomes following a limited approach to radiotherapy in rectal cancer', British Journal of Surgery, vol. 98, pp. 1483 - 1488, http://dx.doi.org/10.1002/bjs.7560

Jacob S; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care', CLINICAL ONCOLOGY, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Jacob SA; Ng W; Asghari R; Delaney GP; Barton MB, 2011, 'Chemotherapy in rectal cancer: variation in utilization and development of an evidencebased benchmark rate of optimal chemotherapy utilization', Clinical Colorectal Cancer, vol. 10, pp. 102 - 107, http://dx.doi.org/10.1016/j.clcc.2011.03.005

Jacob SA; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care', Clinical Oncology, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Barton MB; Dewar JA; Ng W; Jacob S; Speers C; Olivotto I; Delaney GP, 2010, 'A Comparison of Breast Cancer Treatment Rates in British Columbia, Scotland, and Western Australia, and a Comparison with Models of "Optimal" Therapy', CANCER RESEARCH, vol. 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-123-11-11

Ng W; Jacob SA; Delaney GP; Barton MB, 2010, 'Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines', The European Journal of Clinical and Medical Oncology, vol. 2, pp. 65 - 71

Ng W; Delaney GP; Jacob SA; Barton MB, 2010, 'Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best quality cancer care.', European Journal of Cancer, vol. 46, pp. 703 - 712, http://dx.doi.org/10.1016/j.ejca.2009.12.002

Jacob SA; Wong K; Delaney GP; Adams P; Barton MB, 2010, 'Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients', Clinical Oncology, vol. 22, pp. 56 - 64, http://dx.doi.org/10.1016/j.clon.2009.11.003

Jacobs S; Ng W; Ashgari R; Delaney GP; Barton MB, 2009, 'Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care', European Journal of Cancer, vol. 45, pp. 2503 - 2509, http://dx.doi.org/10.1016/j.ejca.2009.05.023

Thompson SR; Delaney GP; Gabriel GS; Jacob SA; Das P; Barton MB, 2008, 'Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence', International Journal of Radiation Oncology and Biology Physics, vol. 72, pp. 849 - 858, http://dx.doi.org/10.1016/j.ijrobp.2008.01.022

Thompson S; Delaney G; Gabriel GS; Jacob S; Das P; Barton M, 2006, 'Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: Review of clinical practice guidelines and primary evidence', Cancer, vol. 107, pp. 2932 - 2941, http://dx.doi.org/10.1002/cncr.22337

Delaney G; Barton M; Jacob S, 2006, 'Erratum: Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: A review of the evidence (Cancer (2004) 101, 4 (657-660))', Cancer, vol. 107, pp. 660, http://dx.doi.org/10.1002/cncr.22056

Delaney G; Jacob S; Featherstone C; Barton M, 2006, 'Erratum: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines (Cancer (2005) 101, 6 (1129-1137))', Cancer, vol. 107, pp. 660, http://dx.doi.org/10.1002/cncr.22057

Thompson SR; Delaney GP; Gabriel GS; Jacobs S; Das P; Barton MB, 2006, 'Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma in the uterine cervix', Cancer, vol. 107, pp. 2932 - 2941

Delaney GP; Jacobs S; Barton MB, 2006, 'Estimating the optimal radiotherapy utilisation for cancer of the central nervous system, thyroid cancer and cancer of unknown primary origin from evidence-based clinical guidelines', Cancer, vol. 106, pp. 453 - 465, http://dx.doi.org/10.1002/cncr.21596

Delaney GP; Jacob SA; Featherstone C; Barton MB, 2006, 'Estimating the Optimal Radiotherapy Utilization Rate Based on Clinical Guidelines and Best Available Evidence and Comparing it to Current Practice', Radiotherapy and Oncology, vol. 80, pp. S2 - S2, http://dx.doi.org/10.1016/S0167-8140(06)80746-2

Delaney GP; Jacob S; Featherstone C; Barton MB, 2005, 'The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines', Cancer, vol. 104, pp. 1129 - 1137, http://dx.doi.org/10.1002/cncr.21324

Delaney GP; Barton MB; Featherstone C; Jacobs S, 2005, 'Estimating the optimal utilisation rates of radiotherapy for hematologic malignancies from a review of the evidence. Part II - Leukaemia and Myelanoma', Cancer, vol. 103, pp. 393 - 401, http://dx.doi.org/10.1002/cncr.20755

Delaney G; Jacob S; Barton M, 2004, 'Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part II - Carcinoma of the endometrium', Cancer, vol. 101, pp. 682 - 692, http://dx.doi.org/10.1002/cncr.20445

Delaney G; Jacob S; Barton M, 2004, 'Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part I - Malignancies of the cervix, ovary, vagina, and vulva', Cancer, vol. 101, pp. 671 - 681, http://dx.doi.org/10.1002/cncr.20444

Delaney GP; Barton MB; Jacobs S, 2004, 'Estimation of an optimal radiotherapy utilization rate for gastro-intstinal carcinoma: a review of evidence', Cancer, vol. 101/4, pp. 657 - 670, http://dx.doi.org/10.1002/cncr.20443

Delaney GP; Barton MB; Jacobs S, 2004, 'Estimation of optimal radiotherapy utilization rate for melanoma: a review of the evidence.', Cancer, vol. 15, pp. 1293 - 1301, http://dx.doi.org/10.1002/cncr.20092

Delaney GP; Barton MB; Jacobs S, 2003, 'Estimation of an optimal radiotherapy utilization rate for breast carcinoma', Cancer, vol. 98, pp. 1977 - 1986, http://dx.doi.org/10.1002/cncr.11740

Barton MB; Dawson R; Jacob S; Currow DC; Stevens G; Morgan GJ, 2001, 'Palliative radiotherapy of bone metastases: an evaluation of outcome measures', Journal of Evaluation in Clinical Practice, vol. 7, pp. 47 - 64, http://dx.doi.org/10.1046/j.1365-2753.2001.00262.x